These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
312 related articles for article (PubMed ID: 8521678)
1. Antidepressant toxicity and the need for identification and concentration monitoring in overdose. Power BM; Hackett LP; Dusci LJ; Ilett KF Clin Pharmacokinet; 1995 Sep; 29(3):154-71. PubMed ID: 8521678 [TBL] [Abstract][Full Text] [Related]
2. Suicidal antidepressant overdoses: a comparative analysis by antidepressant type. White N; Litovitz T; Clancy C J Med Toxicol; 2008 Dec; 4(4):238-50. PubMed ID: 19031375 [TBL] [Abstract][Full Text] [Related]
3. Relative toxicity of venlafaxine and selective serotonin reuptake inhibitors in overdose compared to tricyclic antidepressants. Whyte IM; Dawson AH; Buckley NA QJM; 2003 May; 96(5):369-74. PubMed ID: 12702786 [TBL] [Abstract][Full Text] [Related]
4. Epidemiology and relative toxicity of antidepressant drugs in overdose. Henry JA Drug Saf; 1997 Jun; 16(6):374-90. PubMed ID: 9241492 [TBL] [Abstract][Full Text] [Related]
9. Comparative tolerability profiles of the newer versus older antidepressants. Rudorfer MV; Manji HK; Potter WZ Drug Saf; 1994 Jan; 10(1):18-46. PubMed ID: 8136085 [TBL] [Abstract][Full Text] [Related]
10. Tricyclic Antidepressants and Monoamine Oxidase Inhibitors: Are They Too Old for a New Look? Chockalingam R; Gott BM; Conway CR Handb Exp Pharmacol; 2019; 250():37-48. PubMed ID: 30105472 [TBL] [Abstract][Full Text] [Related]
11. Acute medical costs of fluoxetine versus tricyclic antidepressants. A prospective multicentre study of antidepressant drug overdoses. Revicki DA; Palmer CS; Phillips SD; Reblando JA; Heiligenstein JH; Brent J; Kulig K Pharmacoeconomics; 1997 Jan; 11(1):48-55. PubMed ID: 10165526 [TBL] [Abstract][Full Text] [Related]
12. Fatal serotonin syndrome following a combined overdose of moclobemide, clomipramine and fluoxetine. Power BM; Pinder M; Hackett LP; Ilett KF Anaesth Intensive Care; 1995 Aug; 23(4):499-502. PubMed ID: 7485947 [No Abstract] [Full Text] [Related]
13. Efficacy and tolerability of moclobemide in comparison with placebo, tricyclic antidepressants, and selective serotonin reuptake inhibitors in elderly depressed patients: a clinical overview. Amrein R; Stabl M; Henauer S; Affolter E; Jonkanski I Can J Psychiatry; 1997 Dec; 42(10):1043-50. PubMed ID: 9469236 [TBL] [Abstract][Full Text] [Related]
14. Antidepressants, old and new. A review of their adverse effects and toxicity in overdose. Sarko J Emerg Med Clin North Am; 2000 Nov; 18(4):637-54. PubMed ID: 11130931 [TBL] [Abstract][Full Text] [Related]
15. WITHDRAWN: Treatment discontinuation with selective serotonin reuptake inhibitors (SSRIs) versus tricyclic antidepressants (TCAs). Barbui C; Hotopf M; Freemantle N; Boynton J; Churchill R; Eccles MP; Geddes JR; Hardy R; Lewis G; Mason JM Cochrane Database Syst Rev; 2007 Jul; (3):CD002791. PubMed ID: 17636706 [TBL] [Abstract][Full Text] [Related]
16. The cost of antidepressant overdose. D'Mello DA; Finkbeiner DS; Kocher KN Gen Hosp Psychiatry; 1995 Nov; 17(6):454-5. PubMed ID: 8714807 [TBL] [Abstract][Full Text] [Related]
17. Antidepressant-related deaths and antidepressant prescriptions in England and Wales, 1998-2000. Cheeta S; Schifano F; Oyefeso A; Webb L; Ghodse AH Br J Psychiatry; 2004 Jan; 184():41-7. PubMed ID: 14702226 [TBL] [Abstract][Full Text] [Related]
18. Who develops severe or fatal adverse drug reactions to selective serotonin reuptake inhibitors? Dalfen AK; Stewart DE Can J Psychiatry; 2001 Apr; 46(3):258-63. PubMed ID: 11320680 [TBL] [Abstract][Full Text] [Related]
19. The place for the tricyclic antidepressants in the treatment of depression. Boyce P; Judd F Aust N Z J Psychiatry; 1999 Jun; 33(3):323-7. PubMed ID: 10442787 [TBL] [Abstract][Full Text] [Related]